The global gold nanoparticles market size was valued at USD 7.57 billion in 2023 and is projected to grow at a CAGR of 10.7% from 2024 to 2030. The increasing use of metal nanoparticles in medicine and dentistry, particularly in target imaging and diagnostics, is driving market growth. The rising scope of application in medical imaging due to intrinsic properties is also expected to influence growth positively. According to the study by The Royal Society of Chemistry 2023, gold nanoparticles can enhance image clarity and facilitate precise material reconstruction, potentially resulting in more reliable diagnoses and improved treatment strategies.
Metal nanoparticles possess exceptional properties, such as great absorption with less interference of bone and tissue, high scattering ability, and strong optoacoustic signals for applications in the medical sector. Nanoparticles are also widely accepted in targeted cancer imaging and therapy owing to selective accumulation in tumor cells and high biocompatibility.
Extensive R&D in gold nanotechnology has increased its scope of application in glass technology, pharmaceuticals, photometry, and electronics, among others. Nanoparticles made of gold and silver alter and improve different drug molecules' pharmacodynamic and pharmacokinetic properties. For instance, in February 2024, researchers from Goa University unveiled a groundbreaking discovery in cancer treatment, focusing on the potential of mushrooms to produce gold nanoparticles. These nanoparticles are being studied for their application in developing effective cancer medications. The study highlights how certain mushroom species can synthesize these nanoparticles, which possess unique properties that may enhance the efficacy of cancer therapies. Besides, increasing demand from the electronics industry and gold uses for niche applications like gold nanowires (biosensors) are also driving the market. Nonetheless, strict regulations by regional or national government authorities for using nanomaterials in different products due to health, environmental, and safety issues are affecting the market growth.
Furthermore, the growing diagnostics industry in North America is expected to lead the regional market. High demand for nanotech products in medical diagnostics coupled with rising demand for metal nanoparticles in tumor detection and improved drug delivery systems is also expected to positively impact the regional demand for gold nanoparticles over the forecast period. Moreover, rising spending on R&D activities and innovations in nanoparticle technology is also expected to propel the North American market. The rise in disposable income of consumers and their inclinations towards improved medical treatment and rising awareness for quick diagnosis and fast recovery are also contributing to the gold nanoparticles market growth in the region.
The medical & dentistry segment dominated the market and accounted for a share of 51.7% in 2023 due to the growing application of nanomaterials in medical imaging, therapeutics, and diagnostics. Moreover, increasing funding for R&D for drug delivery systems and cancer-targeting nanoparticle technology is also driving the growth. According to a report published by the National Nanotechnology Initiative (NNI), gold nanoparticles are currently under clinical investigation for their potential in treating cancer and other illnesses. The high demand for nanotechnology-based therapeutics and diagnostics in the medical industry is augmenting the demand for gold nanoparticles. Improvements in medical imaging and nanomedicines drive the demand for quality and superior products. The growing awareness of metal nanoparticles is also expected to fuel the market soon.
The electronics segment is expected to register the fastest CAGR during the forecast period owing to the high demand for compact storage devices and increasing the use of nanotechnology in photovoltaic cells. Furthermore, increasing the use of nanomaterials in nanowires for biosensors is also driving the segment. Nanoparticle printing inks are widely used in USB drives, CDs, DVDs, and internet dongles. Gold nanoparticle inks are also used in photovoltaic cells, photo-sensors and detectors, and thin-film transistors.
North America gold nanoparticles market accounted for a significant market revenue share of in 2023. It is attributable to a well-established healthcare sector in the region. Additionally, growing investments in R&D activities are expected to boost the market in the forthcoming years. Researchers are introducing products that can attract and destroy viruses in the human body. These products will imitate human body cells and cure antimicrobial diseases. Various materials are being introduced for treating skin aging diseases, benefiting the medical sector and driving regional growth.
The U.S. gold nanoparticles market dominated the North America market in 2023 due to advancements in nanotechnology and its applications across various sectors, particularly in biomedical fields. The increasing prevalence of cancer and other chronic diseases has spurred research into targeted drug delivery systems, where gold nanoparticles are utilized for their unique optical properties and biocompatibility. This trend is supported by substantial investments from both public and private sectors into nanomedicine, leading to a surge in clinical trials that leverage gold nanoparticles for imaging and therapeutic purposes.
Europe gold nanoparticles market held a substantial market revenue share in 2023 owing to increased healthcare spending and innovations in in-vitro therapeutics and diagnostics. Moreover, potential demand from Europe due to the growing medical and healthcare domain is expected to contribute to regional growth. Increasing the application scope of nanoparticles in making glass tinting, photovoltaic plates, and fruit protection is an opportunity for the market players. Furthermore, growing niche applications, such as nanowires and fruit and vegetable protection, will also create enormous opportunities for the market in the near future.
The UK gold nanoparticles market is anticipated to grow significantly in the coming years due to the strong pharmaceutical sector, which considerably influences the demand for gold nanoparticles in drug formulation and delivery systems. With major pharmaceutical companies investing heavily in nanomedicine research, there is an increasing need for effective carriers that enhance bioavailability while minimizing side effects. Gold nanoparticles offer unique advantages, such as controlled release mechanisms and improved solubility, making them highly sought after in drug development.
The Asia Pacific gold nanoparticles market accounted for the largest market revenue share of 37.3% in 2023 and is anticipated to register the fastest CAGR over the forecast period. This is attributed to the rising healthcare expenditures among emerging economies. The region’s growing population and increased lifestyle-related diseases have created opportunities for innovative therapeutic solutions utilizing gold nanoparticles. Their application in targeted therapies enhances treatment efficacy and minimizes the adverse effects of conventional treatments.
Japan gold nanoparticles market is expected to grow rapidly in the coming years due to its advanced technological landscape characterized by high levels of investment in research and development across multiple sectors, including electronics, pharmaceuticals, and materials science. Japanese companies are pioneers in integrating nanotechnology into consumer products, thus driving demand for high-quality gold nanoparticles used as conductive materials or catalysts within electronic devices.
Some of the key companies in the gold nanoparticles market include Cytodiagnostics Inc., Goldsol Inc, BBI Solutions, NanoHybrids Inc., and others.
Cytodiagnostics Inc. offers a variety of gold nanoparticle products, such as standard spherical nanoparticles, carboxyl-modified nanoparticles, and gold nanorods. It provides nanoparticles of various sizes and surface functionalities, making them suitable for applications including conjugate development, lateral flow assays, biosensor development, and cellular imaging.
BBI Solutions offers a range of gold nanoparticle products characterized by high stability, uniform size distribution, and customizable surface chemistry. This versatility allows researchers to utilize these nanoparticles in immunoassays, biosensors, and drug delivery systems. The company’s commitment to innovation ensures that its gold nanoparticles meet the stringent requirements of modern scientific research.
The following are the leading companies in the gold nanoparticles market. These companies collectively hold the largest market share and dictate industry trends.
In July 2021, Fortis Life Sciences acquired Nanocomposix, a company in nanomaterials and nanotechnology. This strategic acquisition is expected to enhance Fortis’s capabilities in developing advanced materials for various applications, particularly in the life sciences sector. Nanocomposix has innovative solutions and expertise in producing high-quality nanoparticles essential for research and development in biomedical applications.
Report Attribute |
Details |
Market size value in 2024 |
USD 8.48 billion |
Revenue forecast in 2030 |
USD 15.65 billion |
Growth rate |
CAGR of 10.7% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD Million, Volume in Kilo Grams, and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
End-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Russia; Spain; Australia; South Korea; China; India; Japan; Brazil; Argentina; Saudi Arabia; and South Africa |
Key companies profiled |
Cytodiagnostics Inc.; Goldsol Inc; BBI Solutions; NanoHybrids Inc.; Nanopartz Inc.; Nanosphere Inc.; Nanostellar Inc.; Solaris Nanosciences Corporation; Tanaka Holdings Co. Ltd.; The Metalor Group; Sigma Aldrich |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the gold nanoparticles market report based on end-use and region.
End-use Outlook (Revenue, USD Billion, 2018 - 2030) (Volume, Kilo Grams)
Medical & Dentistry
Electronics
Catalysis
Others
Regional Outlook (Revenue, USD Billion, 2018 - 2030) (Volume, Kilo Grams)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
Japan
India
South Korea
Australia
Central & South America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."